Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study

INTRODUCTION: Injectable semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that was previously shown to be superior to liraglutide and dulaglutide in head-to-head comparisons in GLP-1 RA-naïve individuals. It is hypothesized that semaglutide will cause further reductions in glycat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Akshay B., Kanters, Steve, Khurana, Reena, Kissock, Jagoda, Severin, Naomi, Stafford, Sara G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846659/
https://www.ncbi.nlm.nih.gov/pubmed/33367981
http://dx.doi.org/10.1007/s13300-020-00984-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846659/
https://www.ncbi.nlm.nih.gov/pubmed/33367981
http://dx.doi.org/10.1007/s13300-020-00984-x

Ejemplares similares